Cisplatin Superior to Cetuximab for HPV+ Oropharyngeal Cancer - Infectious Disease Advisor

Cisplatin Superior to Cetuximab for HPV+ Oropharyngeal Cancer  Infectious Disease Advisor

For treatment of HPV positive low-risk oropharyngeal cancer, cetuximab shows no benefit compared with the standard cisplatin regimen in terms of reduced ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2EJoIS2